Bottom line
SPXV vs IXJ: the short answer
SPXV (ProShares S&P 500 Ex-Health Care ETF) and IXJ (iShares Global Healthcare ETF) are both etfs.
But SPXV is far broader, holding 449 positions to 124 for IXJ, so beyond the top names it adds exposure IXJ doesn't have.
SPXV is cheaper at 0.09% vs 0.38% — a difference of $29 a year per $10,000 invested.
Over five years, SPXV returned +15.1% a year vs +6.4% for IXJ.
Updated Nov 19, 2026
SPXV vs IXJ side by side
| SPXV | IXJ | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | ProShares | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 0.38% |
| Annual cost per $10k | $9 | $38 |
| 10-yr cost on $10k (prospectus) | $162 | $480 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +18.1% | +14.9% |
| 5-yr return (annualized) | +15.1% | +6.4% |
| 10-yr return (annualized) | — | +8.2% |
| Best quarter | +21.7% | +13.6% |
| Worst quarter | −20.7% | −11.8% |
| Net assets (fund) | $40.2M | $3.8B |
| Number of holdings | 449 | 124 |
| Portfolio turnover | 4% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SPXV | IXJ | Difference |
|---|---|---|---|
| 2025 | +18.1% | +14.9% | +3.3% |
| 2024 | +28.0% | +0.6% | +27.4% |
| 2023 | +30.7% | +3.5% | +27.2% |
| 2022 | −20.6% | −4.7% | −15.9% |
| 2021 | +28.7% | +19.5% | +9.2% |
| 2020 | +18.9% | +12.5% | +6.5% |
| 2019 | +33.0% | +23.4% | +9.6% |
| 2018 | −6.4% | +2.9% | −9.2% |
| 2017 | +21.4% | +20.3% | +1.1% |
| 2016 | +14.2% | −6.2% | +20.4% |
Source: Fund prospectus bar charts
Holdings overlap
SPXV and IXJ share none of their top holdings.
SPXV top 10
- NVIDIA Corp. — 8.60%
- Apple, Inc. — 7.68%
- Microsoft Corp. — 5.60%
- Amazon.com, Inc. — 4.43%
- Alphabet, Inc. — 3.71%
- Broadcom, Inc. — 3.55%
- Alphabet, Inc. — 2.95%
- Meta Platforms, Inc. — 2.32%
- Tesla, Inc. — 2.05%
- Micron Technology, Inc. — 1.83%
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
FAQ
What is the difference between SPXV and IXJ?
Which is cheaper, SPXV or IXJ?
Should I own both SPXV and IXJ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.